Many Americans Want More Information from Doctors on Genetic Testing

This article originally appeared here.
Share this content:
Many Americans Want Docs to Help Explain Genetic Tests
Many Americans Want Docs to Help Explain Genetic Tests

(HealthDay News) -- When it comes to genetic testing, Americans support more research, laws to protect against discrimination, and involving medical professionals in offering guidance, according to research published online Nov. 7 in Genetics in Medicine.

Rene Almeling, Ph.D., of Yale University in New Haven, Conn., and Shana Kushner Gadarian, Ph.D., of Syracuse University in New York, conducted a survey of a nationally representative sample of 2,100 American adults to assess public opinion on policy issues related to genetics and genomics.

The researchers found that most Americans (82 percent) consider the Genetic Information Nondiscrimination Act of 2008 to be "important." Respondents also showed strong support for clinician involvement in explaining genetic test results (65 percent) and more government funding for genetic research (57 percent). Gender and political party affiliation were significantly associated with policy views.

"As clinicians and professional organizations attempt to persuade federal agencies that direct-to-consumer genetic testing should be more tightly regulated, it is essential to know that the public supports efforts to ensure that clinicians are involved in explaining genetic test results," the authors write.

Full Text (subscription or payment may be required)

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs